CircadifyCircadify
Pricing and Procurement9 min read

How Much Does a Contactless Vitals SDK Cost in 2026?

A 2026 breakdown of contactless vitals SDK pricing models: per-scan, per-seat, and flat license. What CTOs and VP Engineering should budget for camera-based vitals.

getcircadify.com Research Team·
How Much Does a Contactless Vitals SDK Cost in 2026?

Procurement teams evaluating camera-based vitals in 2026 run into the same wall almost immediately: almost no vendor publishes a number. Pricing pages say "contact sales," sales decks defer to a scoping call, and the few public tiers that exist are priced in units like frame credits or sessions that do not map cleanly to a budget line. For a CTO or VP Engineering trying to compare a build-versus-buy decision on a spreadsheet, that opacity is the real cost. This report breaks down contactless vitals SDK pricing the way an engineering buyer actually needs to see it: the three dominant pricing models, what drives the numbers underneath them, and how to model total cost of ownership before you sign anything.

The global remote patient monitoring market reached USD 26.0 billion in 2025 and is projected to hit USD 30.9 billion in 2026, growing at a 20 percent compound annual rate through 2033, according to Grand View Research (2025). That demand is what gives remote photoplethysmography vendors room to charge a premium, and what makes disciplined pricing analysis worth the effort.

Understanding Contactless Vitals SDK Pricing in 2026

Contactless vitals SDK pricing in 2026 is built on three commercial models, sometimes blended into a single contract. The model a vendor pushes tells you a lot about how they expect you to deploy. Remote photoplethysmography (rPPG) runs either on-device or as a cloud API call, and that architectural split is the root of most pricing differences. On-device inference favors per-seat or per-device licensing because the vendor incurs no marginal compute cost per scan. Cloud inference favors per-scan or usage-based billing because every measurement consumes the vendor's GPU time.

The three models you will encounter:

  • Per-scan (usage-based). You pay for each completed measurement, or for a unit like processed frames or a "session." Public developer tiers in this category often start near USD 19 to USD 25 per month for a few hundred scans and climb to a few hundred dollars per month for several thousand. Enterprise volumes move to negotiated per-scan rates that typically fall well below a cent to a few cents per scan at scale.
  • Per-seat / per-device. You pay a recurring fee per active user, per clinician seat, or per installed device. Common in clinical and enterprise deployments where on-device inference removes server cost. Predictable, but expensive if your active user base is large and lightly engaged.
  • Flat license (annual or perpetual). A fixed annual fee, sometimes with a usage ceiling, for unlimited or high-cap deployment. Favored by buyers who need cost certainty and high volume, and by vendors who want committed annual recurring revenue.

The headline rate is rarely the whole bill. Most contracts layer in a platform or integration fee, support tiers, and charges for additional vital signs beyond heart rate. The difference between a quoted rate and the invoice you actually pay is where careful TCO modeling earns its keep.

Per-scan vs license pricing: a side-by-side comparison

The table below models the same notional deployment under each common structure so you can see where the curves cross. Figures are representative industry ranges synthesized from public vendor tiers and procurement reports, not a quote from any single provider.

Pricing model Typical 2026 range Best fit Cost predictability Hidden costs to probe
Per-scan / usage-based ~USD 0.005 to 0.10 per scan; public tiers USD 19 to 199+/mo Variable or seasonal volume, early-stage products Low (scales with usage) Frame vs scan unit, overage rates, minimum commits
Per-seat / per-device ~USD 1 to 10 per active user/mo; enterprise negotiated Clinical, B2B, on-device deployments Medium Definition of "active," device caps, inactive seats
Flat annual license ~USD 25k to 250k+/yr High, steady volume; cost certainty needed High Usage ceilings, true-up clauses, renewal escalators
In-house build ~USD 80k to 350k+ build, plus ongoing ML upkeep Core IP, unusual hardware, long horizon Low early, medium later Validation, camera coverage, maintenance headcount

The in-house row matters because every SDK quote is implicitly competing against your own engineering budget. Independent development-cost estimates put a custom remote patient monitoring build at roughly USD 80,000 to USD 350,000 before ongoing model maintenance, per TechExactly (2025). That figure usually excludes the hardest part of rPPG: maintaining accuracy across skin tones, lighting, motion, and the long tail of phone cameras.

Industry applications and how pricing maps to them

Pricing models are not abstract. The right one depends almost entirely on how your product calls the SDK.

Consumer wellness and fitness apps

High user counts, low scans per user, unpredictable engagement. Per-scan pricing protects you from paying for dormant accounts, but watch overage rates if a feature goes viral. Many consumer teams negotiate a hybrid: a low flat platform fee plus a committed scan bucket with predictable overage pricing.

Telehealth and clinical platforms

Fewer users, higher value per scan, and a strong preference for on-device or in-region processing for compliance. Per-seat licensing aligns with clinician-based access, while flat licenses suit health systems running fixed patient panels. Budget separately for data residency and audit support, which clinical buyers almost always need.

Insurance and enterprise screening

Episodic, high-volume bursts such as underwriting campaigns or workplace screening events. Flat annual licenses with a generous ceiling, or steeply tiered per-scan rates, tend to win here because the buyer values cost certainty over a campaign and can forecast volume in advance.

Current research and evidence

The technical reason pricing varies so widely is that not all rPPG is equally cheap to run or equally accurate to maintain. Camera-based vitals rely on detecting subtle color changes in facial skin tied to the cardiac cycle, and the published validation literature shows accuracy is sensitive to motion, illumination, and skin pigmentation. A 2024 clinical validation study of rPPG pulse-rate monitoring in cardiovascular disease patients, published in MDPI's Bioengineering, reported strong agreement with reference devices under controlled conditions while noting that real-world variability remains the central engineering challenge.

That variability is also a cost driver. Vendors that invest heavily in diverse training data and per-camera tuning carry higher R&D costs and price accordingly, which is one reason a flat license from a mature provider can undercut the fully loaded cost of an in-house team trying to reach the same coverage. Regulatory posture matters too. Some camera-vitals SDKs have pursued formal clearances for specific measurements, and clearance status tends to raise both the price and the appropriate use case toward clinical settings. For wellness and triage products, an uncleared SDK at a lower price point is frequently the rational choice.

When modeling vital signs API cost, the most reliable signal is not the per-unit rate but the unit definition. A vendor charging "per frame" at a low number can cost more per completed measurement than a vendor charging a flat per-scan rate, because a single 30-second scan can consume hundreds of frames. Normalize every quote to cost per completed measurement before you compare.

The future of contactless vitals SDK pricing

Three shifts are reshaping how rPPG SDK cost will be quoted over the next few years.

  • Convergence on cost-per-measurement. As buyers get more sophisticated, expect vendors to publish normalized per-scan equivalents rather than opaque frame or session units. Transparency becomes a competitive feature.
  • On-device default. Cheaper edge inference and tightening privacy expectations are pushing more workloads on-device, which favors per-seat and flat licensing and erodes the pure cloud per-scan model for high-volume cases.
  • Outcome and bundle pricing. Some vendors are beginning to bundle multiple vitals and analytics into a single seat price rather than charging per metric, which simplifies budgeting but requires close reading of what each tier actually includes.

For engineering leaders, the practical takeaway is to treat pricing as a TCO problem, not a sticker problem. Model your realistic scan volume across 12 to 24 months, normalize every vendor quote to cost per completed measurement, and weigh that against a fully loaded in-house estimate that includes ongoing model maintenance, not just the initial build.

Frequently asked questions

What is the typical price range for a contactless vitals SDK in 2026? Public developer tiers commonly start around USD 19 to USD 25 per month for a few hundred scans, while enterprise contracts move to negotiated per-scan rates, per-seat fees, or flat annual licenses that can range from roughly USD 25,000 to USD 250,000 or more depending on volume and vital-sign coverage.

Is per-scan or flat license pricing cheaper? Per-scan is cheaper at low or unpredictable volume; flat licensing wins once your steady volume pushes the blended per-scan cost above the fixed fee. The crossover point depends entirely on your forecast, so model both against your real 12-to-24-month usage.

Why don't vendors publish their pricing? Camera-based vitals deployments vary enormously in volume, vital-sign scope, deployment model, and compliance needs, so most vendors scope a quote per buyer. Asking for cost per completed measurement at your projected volume is the fastest way to cut through it.

Should we build rPPG in-house instead of licensing? Building can make sense if camera vitals are core IP and you have ML staff to maintain accuracy across devices and skin tones. For most teams, a build estimated at USD 80,000 to USD 350,000 plus ongoing upkeep does not beat a license once total cost of ownership is counted.

Circadify is working on this space directly, with a drop-in rPPG SDK designed to get contactless vitals into an app in days rather than months and a pricing model built for engineering buyers who need clear cost-per-measurement math. Teams evaluating build versus buy can review the developer docs, get API keys, and request a tailored quote at circadify.com/custom-builds.

rPPG SDK costhealth monitoring SDK pricingvital signs API costper-scan vs license pricingcontactless vitals
Get API Keys